PFIZER INC Q2 2025 Filing
Filed August 11, 2025
Portfolio Value
$576.2B
Holdings
21
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (21 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BNTXBIONTECH SE | 3,658,361 | $389.5B | 67.60% | |
| 2 | ORICORIC PHARMACEUTICALS INC | 5,376,344 | $54.6B | 9.47% | |
| 3 | ARVNARVINAS INC | 3,457,815 | $25.4B | 4.42% | |
| 4 | ALLOALLOGENE THERAPEUTICS INC | 22,032,040 | $24.9B | 4.32% | |
| 5 | TRMLTOURMALINE BIO INC | 1,272,214 | $20.3B | 3.53% | |
| 6 | WVEWAVE LIFE SCIENCES LTD | 1,875,000 | $12.2B | 2.12% | |
| 7 | PYXSPYXIS ONCOLOGY INC | 7,032,770 | $7.7B | 1.34% | |
| 8 | CRDFCARDIFF ONCOLOGY INC | 2,411,575 | $7.6B | 1.32% | |
| 9 | BHVNBIOHAVEN LTD | 505,645 | $7.1B | 1.24% | |
| 10 | SPROSPERO THERAPEUTICS INC | 2,362,348 | $6.9B | 1.19% | |
| 11 | CRBUCARIBOU BIOSCIENCES INC | 4,690,431 | $5.9B | 1.03% | |
| 12 | CELCCELCUITY INC | 349,406 | $4.7B | 0.81% | |
| 13 | ZURAZURA BIO LTD | 2,970,022 | $3.1B | 0.54% | |
| 14 | EPIEURESSA PHARMA INC | 1,675,000 | $2.8B | 0.49% | |
| 15 | ZNTLZENTALIS PHARMACEUTICALS INC | 953,834 | $1.1B | 0.19% | |
| 16 | NXTCNEXTCURE INC | 157,646 | $870.2M | 0.15% | |
| 17 | ANTXAN2 THERAPEUTICS INC | 715,295 | $758.2M | 0.13% | |
| 18 | QTTBQ32 BIO INC | 277,777 | $413.9M | 0.07% | |
| 19 | BOLTBOLT BIOTHERAPEUTICS INC | 31,305 | $180.6M | 0.03% | |
| 20 | DNAGINKGO BIOWORKS HOLDINGS INC | 2,928 | $32.9M | 0.01% | |
| 21 | SENS1GBPSENSEONICS HLDGS INC | 43,426 | $20.7M | 0.00% |